Anaemia

This information does not replace clinical judgement. Refer to Conditions of use and copyright for further T&Cs.

Anaemia is associated with increased morbidity and mortality in residents of aged care facilities. Early diagnosis and establishing a management plan concordant with the residents goals of care may avoid preventable suffering.

Flowchart

The flowchart shows all of the information at one time. Health professionals should always remain within their scope of practice; these pathways should never replace clinical judgement.

Click the link below to view the full flowchart.

Practice points

A systemised documentation of expanded relevant information - use only in conjunction with flowchart / decision tree above - note you can access each relevant point from the flowchart / decision tree link.

  • Anaemia is a risk factor for increased falls, frailty, decreased cognition, hospitalisation, morbidity and mortality.

    Anaemia is defined by the World Health Organisation as:
    A haemoglobin of less than 120 g per L in women and less than 130 g per L in men
    Consider anaemia in residents who have:

    • Pallor
    • Fatigue
    • Dyspnoea or shortness of breath
    • Headache
    • Restless leg syndrome
    • Symptoms of blood loss e.g. rectal bleeding
    • Worsening or new onset angina
    • Diffuse alopecia or hair loss
    • Tachycardia
    • Syncope
  • Red flags in anaemic residents need to be considered in the context of the residents life trajectory and expressed choices.

    Red flags include:

    A. Severe anaemia < 70g / L in symptomatic resident

    B. Potentially life-threatening complications of anaemia:

    • Haemodynamic compromise: hypotension, pallor, cold clammy skin, tachycardia, dyspnoea
    • Secondary angina (chest pain) or heart failure
    • Acute confusion or altered level of consciousness
    • Syncope or pre-syncope

    C. Persistent or severe abdominal or back pain

    D. Acute bleeding, particularly in those on oral anticoagulants or anti-platelet agents

    • GI bleeding may present with any of: haematemesis (vomiting of blood) OR rectal bleeding OR melaena (black, tarry stools) OR severe back or abdominal pain (abdominal aortic aneurysm)
    • Epistaxis unresponsive to digital pressure on the nose cartilage for 10 minutes or posterior nasal bleeding or haemoptysis
    • Macroscopic haematuria or vaginal bleeding
    • Traumatic bleeding
  • A. Symptoms of:

    • Anaemia (see Definition of, and when to suspect, anaemia - practice point 1)
    • Underlying cause:
      • Bleeding: Gastrointestinal, ENT, vaginal or traumatic bleeding or haematuria, severe abdominal / back pain
      • Underlying coagulation disorder: Excessive bruising
      • Haemolysis: Jaundice and dark urine
      • Haematological malignancy: Night sweats or weight loss
      • Chronic Diseases that may be associated with anaemia of chronic disease
      • Recurrent infections: Pancytopenia

    B. Dietary history including alcohol intake

    C. Medications or supplements that:

    • Cause haemolysis: e.g. penicillin, levodopa, cephalosporins, NSAIDs, clopidogrel
    • Increase bleeding risk e.g. anticoagulants, antiplatelet agents, NSAIDs, corticosteroids, bisphosphonates, ginkgo
    • Affect folate levels or metabolism e.g. alcohol, phenytoin, methotrexate, trimethoprim-sulfamethoxazole
    • Decrease B12 absorption e.g. metformin, colchicine, proton pump inhibitors, histamine blockers
    • Suppress the bone marrow e.g. azathioprine, methotrexate, hydroxyurea

    D. Examination findings:

    • Haemodynamic instability
    • Conjunctival pallor
    • Clinical signs of heart failure
    • Iron deficiency: koilonychia (spoon-shaped nails), angular cheilitis (inflammation of corners of mouth), glossitis (inflamed tongue) and diffuse alopecia (thinning hair), clinical evidence of bleeding, abdominal masses
    • Haemolysis: jaundice, enlarged spleen
    • Underlying malignancy or aplastic anaemia: abnormal bruising, petechiae, lymphadenopathy, enlarged spleen pancytopenia or coagulopathy: petechiae, bruising, spontaneous bleeding e.g. epistaxis, haematuria
  • Reticulocyte count high (>2 per cent)

    Mean corpuscular volume (MCV): normal or elevated
    • Cause: Post-haemorrhage
      • Prevalence: 5-10 per cent
      • Peripheral smear: Polychromasia due to increased reticulocyte count
      • Other: Iron studies initially normal in acute haemorrhage
    • Cause: Haemolysis
      • Prevalence: Uncommon
      • Peripheral smear: Spherocytes, fragments of blood cells
      • Other: Iron studies normal in acute haemolysis; may be reflective of iron deficiency in chronic haemolysis; haemoglobinuria; elevated bilirubin, lactate dehydrogenase (LDH) and reduced haptoglobin

    Reticulocyte count normal or low (<2 per cent)

    Mean corpuscular volume (MCV): Low MCV (<80fL)
    • Cause: Iron deficiency
      • Prevalence: 15 – 30 per cent
      • Peripheral smear: Pencil cells, tear drop cells in severe iron deficiency
      • Other: Serum iron low, total iron binding capacity high, ferritin low; haemoglobin normalises with trial of iron replacement
    Mean corpuscular volume (MCV): Normal or low MCV
    • Cause: Anaemia of chronic disease
      • Prevalence: 30 – 45 per cent
      • Peripheral smear: Burr cells in uraemia; Spur cells in liver disease / renal failure
      • Other: Evidence of renal impairment, liver or hypothyroidism, elevated inflammatory markers; iron studies may show low iron, low total iron binding capacity and ferritin > 100 microg/L
    Mean corpuscular volume (MCV): High MCV (>100fL)
    • Cause: Vitamin B12 and / or folate deficiency
      • Prevalence: 5 – 10 per cent
      • Peripheral smear: Oval macrocytes, hyper-segmented neutrophils; if severe: teardrop poikilocytes and red cell fragments
      • Other: B12 / red cell folate levels low
    • Cause: Myelodysplastic syndrome
      • Prevalence: 5 per cent
      • Peripheral smear: Tear drop cells, oval macrocytosis; hypogranular or hypolobulated neutrophils; blast cells; giant or hypogranular platelets, Pappenheimer bodies, presence of a minor population of hypochromic microcytic cells = dimorphic smear
      • Other: Cytopenias

References

    1. Goodnough LT, Schrier SL. Evaluation and management of anemia in the elderly. Am J Hematol. 2014;89(1):88-96.
    2. World Health Organization. Indicators and Strategies for Iron Deficiency and Anemia Programmes. Report of the WHO/UNICEF/UNU Consultation. Geneva, Switzerland, 1993.
    3. Abid SA, Gravenstein S, Nanda A. Anemia in the Long-Term Care Setting. Clin Geriatr Med. 2019;35(3):381-9.
    4. Joosten E. Strategies for the laboratory diagnosis of some common causes of anaemia in elderly patients. Gerontology. 2004;50(2):49-56.
    5. Gastrointestinal Expert Groups, Therapeutic Guidelines: Gastrointestinal Melbourne: Therapeutic Guidelines limited; 2016.
    6. Smith DL. Anemia in the elderly. Am Fam Physician. 2000;62(7):1565-72.
    7. Bain BJ. Diagnosis from the blood smear. N Engl J Med. 2005;353(5):498-507.
  • Pathway Anaemia 
    Document ID CEQ-HIU-FRAIL-60004
    Version no.1.0.0
    Approval date16/03/2022
    Executive sponsorExecutive Director, Healthcare Improvement Unit
    AuthorImproving the quality and choice of care setting for residents of aged care facilities with acute healthcare needs steering committee
    Custodian Queensland Dementia Ageing and Frailty Network
    Supersedes New
    Applicable to Residential aged care facility registered nurses and General Practitioners in Queensland RACFs, serviced by a RACF acute care support service (RaSS)
    Document source Internal (QHEPS) and external
    AuthorisationExecutive Director, Healthcare Improvement Unit
    Keywords Anaemia, Iron deficiency
    Relevant standards Aged Care Quality Standards:
    Standard 2: ongoing assessments and planning with consumers
    Standard 3: personal care and clinical care, particularly 3(3)
    Standard 8: organisational governance

Last updated: 28 June 2023